Abstract
We systematically reviewed the available literature and meta-analyzed the data which was specialized in Down syndrome (DS) diagnosis with proteomic techniques. Pubmed, EBSCOhost and ScienceDirect searches for relevant articles published from inception until July 2010 were obtained and ten articles were selected. Many candidate biomarkers were found, which could be used to identify Down syndrome. There were 14 markers noted more than two times and 29 best biomarkers were recommended by the authors particularly for clinical application. Application of proteomics contributed to the finding of novel biomarker for prenatal diagnosis of Down syndrome, providing opportunities for the development of non-invasive prenatal diagnosis. Key words: Down syndrome, proteomic, aneuploidy, prenatal diagnosis, meta-analysis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
